Hans-Jörg Martin

1.1k total citations
31 papers, 964 citations indexed

About

Hans-Jörg Martin is a scholar working on Molecular Biology, Cell Biology and Pharmacology. According to data from OpenAlex, Hans-Jörg Martin has authored 31 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Cell Biology and 6 papers in Pharmacology. Recurrent topics in Hans-Jörg Martin's work include Aldose Reductase and Taurine (16 papers), Heme Oxygenase-1 and Carbon Monoxide (6 papers) and Microbial Metabolic Engineering and Bioproduction (5 papers). Hans-Jörg Martin is often cited by papers focused on Aldose Reductase and Taurine (16 papers), Heme Oxygenase-1 and Carbon Monoxide (6 papers) and Microbial Metabolic Engineering and Bioproduction (5 papers). Hans-Jörg Martin collaborates with scholars based in Germany, United Kingdom and Czechia. Hans-Jörg Martin's co-authors include Edmund Maser, M.C. Allwood, U. Breyer-Pfaff, Günter Fred Fuhrmann, Vladimı́r Wsól, Bettina Ebert, Simone Venz, A. C. van der Linden, Michael Gülden and Hasso Seibert and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Biochimica et Biophysica Acta (BBA) - Biomembranes.

In The Last Decade

Hans-Jörg Martin

31 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans-Jörg Martin Germany 16 430 323 133 127 125 31 964
Sang Mi Shin South Korea 23 932 2.2× 149 0.5× 193 1.5× 32 0.3× 126 1.0× 35 1.6k
Sayantani Chowdhury India 11 311 0.7× 98 0.3× 106 0.8× 20 0.2× 136 1.1× 12 950
Maria Chatzopoulou Greece 16 355 0.8× 297 0.9× 25 0.2× 73 0.6× 78 0.6× 31 826
Martine Chevanne France 19 500 1.2× 208 0.6× 60 0.5× 28 0.2× 28 0.2× 31 1.3k
Cátia V. Diogo Portugal 15 408 0.9× 89 0.3× 109 0.8× 20 0.2× 58 0.5× 21 943
Ranjinder S. Sidhu Canada 13 426 1.0× 99 0.3× 63 0.5× 68 0.5× 39 0.3× 14 1.1k
M. Kraml United States 18 396 0.9× 94 0.3× 171 1.3× 55 0.4× 115 0.9× 66 1.2k
Yenjerla Mythili India 19 320 0.7× 79 0.2× 93 0.7× 35 0.3× 27 0.2× 22 796
T. Noguchi Japan 19 486 1.1× 58 0.2× 214 1.6× 36 0.3× 79 0.6× 40 1.2k
Yukio Nisimoto Japan 16 525 1.2× 83 0.3× 124 0.9× 44 0.3× 42 0.3× 35 1.3k

Countries citing papers authored by Hans-Jörg Martin

Since Specialization
Citations

This map shows the geographic impact of Hans-Jörg Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans-Jörg Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans-Jörg Martin more than expected).

Fields of papers citing papers by Hans-Jörg Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans-Jörg Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans-Jörg Martin. The network helps show where Hans-Jörg Martin may publish in the future.

Co-authorship network of co-authors of Hans-Jörg Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Hans-Jörg Martin. A scholar is included among the top collaborators of Hans-Jörg Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans-Jörg Martin. Hans-Jörg Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brandt, T., et al.. (2024). Light-switchable diazocines as potential inhibitors of testosterone-synthesizing 17β-hydroxysteroid dehydrogenase 3. Chemico-Biological Interactions. 390. 110872–110872. 2 indexed citations
2.
Strehse, Jennifer S., et al.. (2022). Carbonyl reduction of 4-oxonon-2-enal (4-ONE) by Sniffer from D. magna and D. pulex. Chemico-Biological Interactions. 354. 109833–109833. 1 indexed citations
3.
Çiçek, Serhat Sezai, et al.. (2022). Inhibition of human carbonyl reducing enzymes by plant anthrone and anthraquinone derivatives. Chemico-Biological Interactions. 354. 109823–109823. 5 indexed citations
4.
5.
Hornung, Jan, et al.. (2014). Curcumin is a tight-binding inhibitor of the most efficient human daunorubicin reductase – Carbonyl reductase 1. Chemico-Biological Interactions. 234. 162–168. 24 indexed citations
6.
Staab-Weijnitz, Claudia A., Bettina Ebert, Michael Kisiela, et al.. (2011). Studies on reduction of S-nitrosoglutathione by human carbonyl reductases 1 and 3. Chemico-Biological Interactions. 191(1-3). 95–103. 19 indexed citations
8.
Linden, A. C. van der, Michael Gülden, Hans-Jörg Martin, Edmund Maser, & Hasso Seibert. (2008). Peroxide-induced cell death and lipid peroxidation in C6 glioma cells. Toxicology in Vitro. 22(5). 1371–1376. 74 indexed citations
9.
Martin, Hans-Jörg & Edmund Maser. (2008). Role of human aldo–keto-reductase AKR1B10 in the protection against toxic aldehydes. Chemico-Biological Interactions. 178(1-3). 145–150. 92 indexed citations
10.
Martin, Hans-Jörg, et al.. (2005). PURIFICATION AND CHARACTERIZATION OF AKR1B10 FROM HUMAN LIVER: ROLE IN CARBONYL REDUCTION OF XENOBIOTICS. Drug Metabolism and Disposition. 34(3). 464–470. 99 indexed citations
11.
Xiong, Guangming, Hans-Jörg Martin, & Edmund Maser. (2003). Identification and Characterization of a Novel Translational Repressor of the Steroid-inducible 3α-Hydroxysteroid Dehydrogenase/Carbonyl Reductase Gene in Comamonas testosteroni. Journal of Biological Chemistry. 278(48). 47400–47407. 32 indexed citations
12.
Martin, Hans-Jörg, et al.. (2003). The inhibitory effects of flavonoids and antiestrogens on the Glut1 glucose transporter in human erythrocytes. Chemico-Biological Interactions. 146(3). 225–235. 69 indexed citations
13.
Blum, Andreas, et al.. (2001). Human 11β-hydroxysteroid dehydrogenase 1/carbonyl reductase: additional domains for membrane attachment?. Chemico-Biological Interactions. 130-132(1-3). 749–759. 9 indexed citations
14.
Xiong, Guangming, et al.. (2001). A model on the regulation of 3α-hydroxysteroid dehydrogenase/carbonyl reductase expression in Comamonas testosteroni. Chemico-Biological Interactions. 130-132(1-3). 723–736. 10 indexed citations
15.
Allwood, M.C. & Hans-Jörg Martin. (2000). The photodegradation of vitamins A and E in parenteral nutrition mixtures during infusion. Clinical Nutrition. 19(5). 339–342. 59 indexed citations
16.
Blum, Andreas, Hans-Jörg Martin, & Edmund Maser. (2000). Human 11β-Hydroxysteroid Dehydrogenase Type 1 Is Enzymatically Active in Its Nonglycosylated Form. Biochemical and Biophysical Research Communications. 276(2). 428–434. 28 indexed citations
17.
Fuhrmann, Günter Fred, Eckhard Boles, Andreas Maier, Hans-Jörg Martin, & Bernhard Völker. (1998). Glucose transport kinetics inSaccharomyces cerevisiae cells and in strains with single glucose transporter. Folia Microbiologica. 43(2). 194–194. 1 indexed citations
18.
Völker, Bernhard, Hans-Jörg Martin, David J. Michaelis, & Günter Fred Fuhrmann. (1997). Is there a channel for glucose in the plasma membrane ofSaccharomyces cerevisiae?. Folia Microbiologica. 42(3). 250–251. 4 indexed citations
19.
Völker, Bernhard, et al.. (1997). Different activation energies in glucose uptake in Saccharomyces cerevisiae DFY1 suggest two transport systems. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1325(1). 126–134. 13 indexed citations
20.
Allwood, M.C. & Hans-Jörg Martin. (1996). Long-term stability of cimetidine in total parenteral nutrition. Journal of Clinical Pharmacy and Therapeutics. 21(1). 19–21. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026